Navigation Links
Vaginal delivery is the safest option for women with pelvic girdle pain
Date:1/17/2013

Caesarean section increases the risk of persistent pelvic girdle pain after delivery compared with vaginal delivery, according to a new study from the Norwegian Institute of Public Health.

Caesarean section rates are increasing worldwide, and this trend has partly been explained by women's requests for planned caesarean section without a medical reason. Pregnancy-related pelvic girdle pain has been associated with increased preference for caesarean section and with increased planned caesarean section rates.

"Some women with severe pelvic girdle pain might fear that a vaginal delivery will be too difficult or painful, or will worsen the condition after delivery even though scientific evidence is lacking", says Elisabeth K. Bjelland, who is a postdoctoral researcher at the Institute's Division of Mental Health and lead author of the study.

Knowledge about how caesarean section affects prognosis of pelvic girdle pain is therefore needed. The purpose of this study was to investigate the relationship between mode of delivery and the persistence of pelvic girdle pain six months after delivery.

In this follow-up study, 79.9% of women had unassisted vaginal deliveries, 6.7% had instrumental vaginal deliveries (by vacuum or forceps), 7.2% had emergency caesarean sections and 6.2% had planned caesarean sections.

Doubles the risk of pain after delivery

After taking a number of other factors into account, the results showed that:

  • Planned caesarean section was associated with a two- to threefold increased risk of severe pelvic girdle syndrome (severe pain over the frontal part of the pelvis and on both sides of the rear part of the pelvis) six months after delivery.

  • In women who used crutches in pregnancy, both emergency and planned caesarean section was associated with severe pelvic girdle syndrome six months after delivery.

  • Instrumental vaginal delivery was also associated with an
    '/>"/>

Contact: Julie Johansen
julie.johansen@fhi.no
Norwegian Institute of Public Health
Source:Eurekalert

Page: 1 2

Related biology news :

1. Reduced glycerin formulation of tenofovir vaginal gel safe for rectal use
2. Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm
3. Delivery of gene-therapy for heart disease boosted 100-fold; now in 100-patient trial
4. Light-induced delivery of nitric oxide eradicates drug-resistant bacteria
5. Oligonucleotide Delivery: Biology, Engineering and Development Conference
6. Elegant delivery
7. Pilot Results Move GHX Closer to Delivery of Healthcare Industrys First Implantable Device Supply Chain Solution
8. University of Leicester takes delivery of unique eye imaging equipment
9. Body heat, fermentation drive new drug-delivery micropump
10. UC Davis researchers develop new drug delivery system for bladder cancer using nanoparticles
11. Aware Enables Automated Delivery of Radiation Dose Information Through Integration With Leading Radiology Reporting System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... , May 26, 2015 ... the addition of the "Saudi Arabia Biometric ... to their offering. ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ,The ... is projected to grow at over ... growth is attributed to the surging demand for ...
(Date:5/25/2015)... , May 25, 2015  Australia,s market for ... stage, although 2014 saw the advent of several trials ... 24 April 2015 is expected to ignite interest in ... in Australia . This in turn ... industry and drive new partnerships amongst vendors and distributors. ...
(Date:5/22/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") ... promotional pricing and making the Wocket generally available for $229 ... Head of Marketing said, "We,ve extended the opportunity to take ... May. To get your wocket at this special price, submit ... on June 1, you,ll receive a unique code that gives ...
Breaking Biology News(10 mins):Saudi Arabia Biometric Systems Market Forecast and Opportunities, 2020 with Morpho Safran, ZK Technlogy, and Suprema Dominating 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3
... A world-class St. Augustine spa called “perfect” by past ... a “perfect 10” business opportunity for entrepreneurs with an eye for beauty and ... Designed by renowned ... is part of the highly-rated Laterra Resort, located in the World Golf Village ...
... April 27 /PRNewswire-FirstCall/ - Aeterna Zentaris Inc. (NASDAQ: ... development company specialized in oncology and endocrinology, announced today that ... notifying it that the closing price per share of the ... bid price for 10 consecutive trading days and that, as ...
... be able to survive the harsh environs of Mars ... according to research published in the April 2010 issue ... The search for life on Mars remains a ... Institutes. To preserve the pristine environments, the bioloads on ...
Cached Biology News:Plastic Surgeons Rate Auction of World-Class Florida Laterra Spa May 21 a 'Perfect 10,' Great Business Opp for Celebrity Retreat 2Plastic Surgeons Rate Auction of World-Class Florida Laterra Spa May 21 a 'Perfect 10,' Great Business Opp for Celebrity Retreat 3Plastic Surgeons Rate Auction of World-Class Florida Laterra Spa May 21 a 'Perfect 10,' Great Business Opp for Celebrity Retreat 4
(Date:5/26/2015)... NORTH CHICAGO, Ill. , May 26, 2015 ... biopharmaceutical company, announced today that it has completed ... and commercial presence in oncology. Pharmacyclics is a ... (ibrutinib), a first-in-class BTK-inhibitor used to treat hematological ... "The companies, shared expertise, combined with AbbVie,s broad ...
(Date:5/25/2015)... a science-driven healthcare company seeking to solve some of ... that Dame Marjorie Scardino , Chairman of the ... appointed to PureTech,s Board of Directors in the role ... Joi Ito , MIT Media Lab,s Director, has ... PureTech,s outgoing Chairman and co-founder, former Executive Vice President ...
(Date:5/22/2015)... DUBLIN , May 22, 2015  Actavis plc ... of the U.S. Court of Appeals for the Second ... 2014 preliminary injunction requiring the Company to continue distribution ... Logo - http://photos.prnewswire.com/prnh/20130124/NY47381LOGO   ... uphold this ruling, we intend to continue our strong ...
(Date:5/22/2015)... -- Baylor Research Institute (BRI) at ... (TGen) in Phoenix, AZ , today ... and treatments for patients with a broad range of cancers. ... new clinical trials and access to technology to drive the ... to bedside across Baylor Scott & White Health,s ...
Breaking Biology Technology:AbbVie Completes Acquisition of Pharmacyclics 2AbbVie Completes Acquisition of Pharmacyclics 3AbbVie Completes Acquisition of Pharmacyclics 4AbbVie Completes Acquisition of Pharmacyclics 5AbbVie Completes Acquisition of Pharmacyclics 6PureTech Adds Dame Marjorie Scardino to Board of Directors, Names Joi Ito as Chairman of the Board and Expands Management Team 2PureTech Adds Dame Marjorie Scardino to Board of Directors, Names Joi Ito as Chairman of the Board and Expands Management Team 3Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 2Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 3Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 4Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 5Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 6Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 7Actavis Confirms Appeals Court Ruling Requiring Continued Distribution of NAMENDA IR 8Precision Medicine Collaboration to Increase Options for Cancer Patients 2Precision Medicine Collaboration to Increase Options for Cancer Patients 3Precision Medicine Collaboration to Increase Options for Cancer Patients 4
... CHEADLE, England, BURLINGTON, Massachusetts and RAMBOUILLET, ... a maker of model-based,vision software for ... a developer of High Resolution Digital ... quantitative analysis of joint and bone,tissues, ...
... Documentation Technology, ... Services to Provista, ... as,the first awarded supplier of medical transcription technology and services,by ... parties, agreement, Spheris will provide Provista customers with,a full range ...
... to be Webcast at 2:00 pm ET on November ... Corporation (Nasdaq: TARG ) today announced its participation,in ... November 27 and 28, 2007 at the New York ... Chief Executive Officer of,Targanta, will be presenting at 2:00 ...
Cached Biology Technology:Rapid Quantification of Osteoarthritis With a Novel, Office-Based, High-Resolution Digital Imaging Device 2Provista Awards Agreement to Spheris 2Targanta to Present at Lazard Capital Markets Fourth Annual Healthcare Conference 2
Anti-human C3a/C3a des-Arg (neo-epitope), Clone 2991, Monoclonal Antibody...
Phospho-FADD (Ser194) Antibody (Human Specific)...
... polyclonal to FANCM ( Abpromise for ... Synthetic peptide derived from within residues ... (Note: the amino acid sequence is ... ab27787 .) Entrez ...
Rabbit polyclonal to WWOX8 ( Abpromise for all tested applications). entrezGeneID: 51741 SwissProtID: Q9NZC7-8...
Biology Products: